Abstract
Aim Midline head positioning for preterm infants in the first 72 hours of life may prevent intraventricular hemorrhage (IVH). The feasibility of conducting a RCT was explored, namely (1) acceptability of the recruitment and consenting process, (2) practicality of recruitment within 4 hours of life, (3) protocol compliance, and (4) staff satisfaction with the intervention. Methods An open-label, single center, balanced 1:1 allocation, parallel-group pilot RCT was adopted. Inborn infants <29 weeks admitted to the NICU with no IVH on screening ultrasound and parental consent obtained within 4 hours of birth were randomized to either midline head and supine body position (intervention) or variable position (control) for 72 hours, stratified according to gestation. Measures were recruitment rate, time to complete recruitment, protocol compliance audit, and staff satisfaction survey. Results Sixty participants were enrolled with recruitment rate of 67%. Recruitment and intervention were commenced by 6 hours. Compliance was 98% for midline head position. Nursing satisfaction was positive in 30/33 (91%). No safety issues were reported for stability, skin integrity, comfort, pain, and head preference. Conclusion It is feasible and safe to conduct a RCT to examine the neuroprotective effects of positioning the preterm infant in the first 72 hours of life.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The PIN study was registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12619000276156).
Funding Statement
We acknowledge funding support for this study from Project Grants (PG08518, PG13917) awarded by the Research Foundation, Cerebral Palsy Alliance.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Western Sydney Local Health District gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets generated during and/or analysed during the current study are not publicly available due to original ethics committee specifications but are available from the corresponding author on reasonable request and with ethics compliance.
